CN Patent

CN114126582A — 局部用组合物

Assigned to Bausch Health Ireland Ltd · Expires 2022-03-01 · 4y expired

What this patent protects

本发明提供了局部用凝胶制剂，其包含1‑1.5％重量的克林霉素磷酸酯、2.5‑3.5％重量的过氧化苯甲酰和0.1‑0.2％重量的阿达帕林，以及胶凝剂、多元醇和水，用于治疗包括痤疮在内的炎症性皮肤病，以及其制备和使用方法。

USPTO Abstract

本发明提供了局部用凝胶制剂，其包含1‑1.5％重量的克林霉素磷酸酯、2.5‑3.5％重量的过氧化苯甲酰和0.1‑0.2％重量的阿达帕林，以及胶凝剂、多元醇和水，用于治疗包括痤疮在内的炎症性皮肤病，以及其制备和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114126582A
Jurisdiction
CN
Classification
—
Expires
2022-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Bausch Health Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.